Literature DB >> 17519355

Response of SMRT (silencing mediator of retinoic acid and thyroid hormone receptor) and N-CoR (nuclear receptor corepressor) corepressors to mitogen-activated protein kinase kinase kinase cascades is determined by alternative mRNA splicing.

Brian A Jonas1, Natalia Varlakhanova, Fumihiko Hayakawa, Michael Goodson, Martin L Privalsky.   

Abstract

The SMRT (silencing mediator of retinoic acid and thyroid hormone receptor) and N-CoR (nuclear receptor corepressor) corepressors are important mediators of transcriptional repression by nuclear hormone receptors. SMRT is regulated by MAPK kinase kinase (MAPKKK) cascades that induce its release from its receptor partners, its export from nucleus to cytoplasm, and derepression of target gene expression. Intriguingly, the otherwise closely related N-CoR is refractory to MAPKKK signaling under the same conditions. However, both SMRT and N-CoR are expressed as a series of alternatively spliced protein variants differing in structure and function. We have now characterized the impact of this alternative mRNA splicing on the corepressor response to MAPKKK signaling. Whereas the SMRTalpha, SMRTtau, and SMRTsp2 splice variants are released from their nuclear receptor partners in response to MAPKKK activation, the SMRTsp18 variant, which resembles N-CoR in its overall molecular architecture, is relatively refractory to this kinase-induced release. Alternative splicing of N-CoR, in contrast, had only minimal effects on the resistance of this corepressor to MAPKKK inhibition. Notably, all of the SMRT splice variants examined redistributed from nucleus to cytoplasm in response to MAPKKK cascade signaling, but none of the N-CoR splice variants did so. Different tiers of the MAPKKK cascade hierarchy contributed to these different aspects of corepressor regulation, with MAP/ERK kinase kinase 1 and MAP/ERK kinase 1 regulating subcellular redistribution and ERK2 regulating nuclear receptor-corepressor interaction. We conclude that cells can customize their transcriptional response to MAPKKK cascade signaling by selective expression of the SMRT or N-CoR locus, by selective utilization of a specific corepressor splice variant, and by selective exploitation of specific tiers of the MAPK cascade.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17519355      PMCID: PMC2675559          DOI: 10.1210/me.2007-0035

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  84 in total

Review 1.  Nuclear receptor coactivators: multiple enzymes, multiple complexes, multiple functions.

Authors:  N J McKenna; J Xu; Z Nawaz; S Y Tsai; M J Tsai; B W O'Malley
Journal:  J Steroid Biochem Mol Biol       Date:  1999 Apr-Jun       Impact factor: 4.292

Review 2.  Coregulator codes of transcriptional regulation by nuclear receptors.

Authors:  M G Rosenfeld; C K Glass
Journal:  J Biol Chem       Date:  2001-07-17       Impact factor: 5.157

3.  Activation of ERK induces phosphorylation of MAPK phosphatase-7, a JNK specific phosphatase, at Ser-446.

Authors:  Kouhei Masuda; Hiroshi Shima; Chiaki Katagiri; Kunimi Kikuchi
Journal:  J Biol Chem       Date:  2003-06-06       Impact factor: 5.157

4.  Identification of TRACs (T3 receptor-associating cofactors), a family of cofactors that associate with, and modulate the activity of, nuclear hormone receptors.

Authors:  S Sande; M L Privalsky
Journal:  Mol Endocrinol       Date:  1996-07

5.  Human HDAC7 histone deacetylase activity is associated with HDAC3 in vivo.

Authors:  W Fischle; F Dequiedt; M Fillion; M J Hendzel; W Voelter; E Verdin
Journal:  J Biol Chem       Date:  2001-07-20       Impact factor: 5.157

6.  Multiple N-CoR complexes contain distinct histone deacetylases.

Authors:  P L Jones; L M Sachs; N Rouse; P A Wade; Y B Shi
Journal:  J Biol Chem       Date:  2001-01-19       Impact factor: 5.157

7.  Retinoic acid receptors beta and gamma do not repress, but instead activate target gene transcription in both the absence and presence of hormone ligand.

Authors:  Herborg Hauksdottir; Behnom Farboud; Martin L Privalsky
Journal:  Mol Endocrinol       Date:  2002-12-23

8.  Phosphorylation of PML by mitogen-activated protein kinases plays a key role in arsenic trioxide-mediated apoptosis.

Authors:  Fumihiko Hayakawa; Martin L Privalsky
Journal:  Cancer Cell       Date:  2004-04       Impact factor: 31.743

9.  A 10-amino-acid sequence in the N-terminal A/B domain of thyroid hormone receptor alpha is essential for transcriptional activation and interaction with the general transcription factor TFIIB.

Authors:  E Hadzic; V Desai-Yajnik; E Helmer; S Guo; S Wu; N Koudinova; J Casanova; B M Raaka; H H Samuels
Journal:  Mol Cell Biol       Date:  1995-08       Impact factor: 4.272

10.  Constitutive activation of extracellular signal-regulated kinase 2 by synergistic point mutations.

Authors:  M A Emrick; A N Hoofnagle; A S Miller; L F Ten Eyck; N G Ahn
Journal:  J Biol Chem       Date:  2001-10-08       Impact factor: 5.157

View more
  18 in total

1.  SMRTε, a corepressor variant, interacts with a restricted subset of nuclear receptors, including the retinoic acid receptors α and β.

Authors:  Brenda J Mengeling; Michael L Goodson; William Bourguet; Martin L Privalsky
Journal:  Mol Cell Endocrinol       Date:  2012-01-12       Impact factor: 4.102

2.  Alternative mRNA splicing of corepressors generates variants that play opposing roles in adipocyte differentiation.

Authors:  Michael L Goodson; Brenda J Mengeling; Brian A Jonas; Martin L Privalsky
Journal:  J Biol Chem       Date:  2011-11-07       Impact factor: 5.157

Review 3.  Cell signaling and nuclear receptors: new opportunities for molecular pharmaceuticals in liver disease.

Authors:  Jeff L Staudinger; Kristin Lichti
Journal:  Mol Pharm       Date:  2007-12-27       Impact factor: 4.939

4.  Thyroid hormone receptor mutations found in renal clear cell carcinomas alter corepressor release and reveal helix 12 as key determinant of corepressor specificity.

Authors:  Meghan D Rosen; Martin L Privalsky
Journal:  Mol Endocrinol       Date:  2009-04-30

Review 5.  Crosstalk in inflammation: the interplay of glucocorticoid receptor-based mechanisms and kinases and phosphatases.

Authors:  Ilse M E Beck; Wim Vanden Berghe; Linda Vermeulen; Keith R Yamamoto; Guy Haegeman; Karolien De Bosscher
Journal:  Endocr Rev       Date:  2009-11-04       Impact factor: 19.871

Review 6.  Emerging roles of the corepressors NCoR1 and SMRT in homeostasis.

Authors:  Adrienne Mottis; Laurent Mouchiroud; Johan Auwerx
Journal:  Genes Dev       Date:  2013-04-15       Impact factor: 11.361

7.  The ability of thyroid hormone receptors to sense t4 as an agonist depends on receptor isoform and on cellular cofactors.

Authors:  Amy Schroeder; Robyn Jimenez; Briana Young; Martin L Privalsky
Journal:  Mol Endocrinol       Date:  2014-03-27

8.  Thyroid hormone signaling in vivo requires a balance between coactivators and corepressors.

Authors:  Kristen R Vella; Preeti Ramadoss; Ricardo H Costa-E-Sousa; Inna Astapova; Felix D Ye; Kaila A Holtz; Jamie C Harris; Anthony N Hollenberg
Journal:  Mol Cell Biol       Date:  2014-02-18       Impact factor: 4.272

9.  The nuclear corepressor, NCoR, regulates thyroid hormone action in vivo.

Authors:  Inna Astapova; Larissa J Lee; Crystal Morales; Stefanie Tauber; Martin Bilban; Anthony N Hollenberg
Journal:  Proc Natl Acad Sci U S A       Date:  2008-12-03       Impact factor: 11.205

Review 10.  Vitamin A and retinoid signaling: genomic and nongenomic effects.

Authors:  Ziad Al Tanoury; Aleksandr Piskunov; Cécile Rochette-Egly
Journal:  J Lipid Res       Date:  2013-02-24       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.